Ready for a demo?

We’re happy to provide an overview of what full access to Drug Hunter offers, including scientifically rich molecule case studies, patent highlights and reviews packed with insights to help you solve your greatest drug discovery challenges. Please fill out the form below and a member of our team will be in touch shortly.

Request a Demo

“Drug Hunter saves me days, if not weeks of reading each month.”

You don't have time to read everything, but you can't afford to fall behind.

Drug Hunter Premium is created by scientists for scientists, so you can quickly catch up and make informed decisions based on industry examples.

Get access to:

hundreds of drug discovery case studies

scientific reviews

conference and news highlights

structure search

... and more

From Our Members

“Drug Hunter’s articles have become one of my favorite reads, from Molecules of the Month and FDA approval articles to the cheat sheets and calculation tools. As a DMPK scientist, I’ve used it as a main resource to keep up with drug discovery trends, cutting-edge science, and important developments to broaden..."

Dian Su

Senior Director, DMPK

Dian Su

Senior Director, DMPK

“I continue to be surprised on how the issues your publication touches on routinely seems to impact our work lives in the sense of prompting conversations, prompting literature or patent searches based on the work of others facing similar challenges. The value of this very direct effect can’t be overstated gi..."

Peter Meinke

Sanders Director, Tri-I TDI + 28 yrs at Merck

“Drug Hunter has been great. I regularly check with my team and they all say they like it and use it. My team has benefited from this site with keeping up to date of the latest and greatest. Drug Hunter provides facts, data and information that we can learn from. I have even used some of the sites info in my ..."

Anthony Romero

Sr. Director, Head of Chemistry, ORIC Pharma, prev. Genentech, Merck